In the TCGA cohort, FXYD2 mRNA expression was also downregulated in 539 ccRCC compared to 72 normal tissue (P < 0.0001) (Figures 1(g)–1(h)). The gene discussed is FXYD2; the disease is nonpapillary renal cell carcinoma.